Jean‐Pierre Maffrand

7.2k citations

90 papers · 5.8k indexed · 1 hit paper · h-index 36

Molecular Biology top 5%
Cardiology and Cardiovascular Medicine top 1%
Cellular and Molecular Neuroscience top 1%
Pharmacology top 0.5%
Surgery top 5%

Co-authors: Jean‐Marc Herbert Marc Pascal Philippe Soubrié Pierre Savi Gérard Le Fur Jean‐Marie Pereillo C. Picard Claudine Serradeil‐Le Gal
Topics: Receptor Mechanisms and Signaling (19 papers)Neuropeptides and Animal Physiology (15 papers)Synthesis and Reactivity of Sulfur-Containing Compounds (10 papers)
Cited by: Behavioral Neuroscience Endocrine and Autonomic Systems Internal Medicine
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: France Italy Switzerland

In The Last Decade

Jean‐Pierre Maffrand

90 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Biological Activity of the Active Metabolite of Clopidogrel

2000 562 citations Pierre Savi, Jean‐Marie Pereillo et al. profile →

Peers

Countries citing papers authored by Jean‐Pierre Maffrand

Since Specialization

Citations

This map shows the geographic impact of Jean‐Pierre Maffrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Maffrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Maffrand more than expected).

Fields of papers citing papers by Jean‐Pierre Maffrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Maffrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Maffrand. The network helps show where Jean‐Pierre Maffrand may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Maffrand

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Maffrand. A scholar is included among the top collaborators of Jean‐Pierre Maffrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Maffrand. Jean‐Pierre Maffrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The story of clopidogrel and its predecessor, ticlopidine: Could these major antiplatelet and antithrombotic drugs be discovered and developed today? 2012 ·Comptes Rendus Chimie ·Jean‐Pierre Maffrand	37
2	SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal,(unknown),(unknown),Guy Germain,Charles Advenier,Emmanuel Naline,Marc Bardou,(unknown),Brigitte Pouzet,Danielle Raufaste,Corinne Garcia,(unknown),(unknown),Marc Pascal,A. Barbier,B. Scatton,Jean‐Pierre Maffrand,Gérard Le Fur	41
3	Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders 2002 ·Proceedings of the National Academy of Sciences ·Guy Griebel,Jacques Simiand,Claudine Serradeil‐Le Gal,Jean Wagnon,Marc Pascal,B. Scatton,Jean‐Pierre Maffrand,Philippe Soubrié	381
4	Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal,Jean Wagnon,Jacques Simiand,Guy Griebel,C Lacour,Gilles Guillon,Claude Barberis,(unknown),Philippe Soubrié,Dino Nisato,Marc Pascal,Rebecca M. Pruss,B. Scatton,Jean‐Pierre Maffrand,Gérard Le Fur	180
5	Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors 2002 ·European Journal of Pharmacology ·Marco Landi,Tiziano Croci,Murielle Rinaldi‐Carmona,Jean‐Pierre Maffrand,Gérard Le Fur,L. Manara	72
6	Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK₃ receptor antagonist 2002 ·Canadian Journal of Physiology and Pharmacology ·Xavier Emonds‐Alt,Vincenzo Proietto,R. Steinberg,Charles Advenier,(unknown),Emmanuel Naline,Christiane Gueudet,(unknown),Florence Oury-Donat,Martine Poncelet,P. Vilain,Gérard Le Fur,Jean‐Pierre Maffrand,Philippe Soubrié,Marc Pascal	26
7	Structure and Stereochemistry of the Active Metabolite of Clopidogrel 2002 ·Drug Metabolism and Disposition ·Jean‐Marie Pereillo,Mohamed Maftouh,(unknown),(unknown),Olivier Fedeli,Pierre Savi,Marc Pascal,Jean‐Marc Herbert,Jean‐Pierre Maffrand,C. Picard	356
8	Effect of SR121463, a Selective Non-Peptide Vasopressin V ₂ Receptor Antagonist, in a Rabbit Model of Ocular Hypertension 2000 ·Journal of Ocular Pharmacology and Therapeutics ·F. Lacheretz,A. Barbier,(unknown),(unknown),Jean‐Pierre Maffrand,(unknown)	17
9	In vitro characterization of tachykinin NK₂‐receptors modulating motor responses of human colonic muscle strips 1998 ·British Journal of Pharmacology ·Tiziano Croci,(unknown),L. Manara,Xavier Emonds‐Alt,Gérard Le Fur,Jean‐Pierre Maffrand,Sylvain Mukenge,Gianfranco Ferla	40
10	A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 1997 ·Journal of Biological Chemistry ·Monsif Bouaboula,(unknown),Laura Milligan,Xavier Canat,Murielle Rinaldi‐Carmona,Marielle Portier,Francis Barth,Bernard Calandra,Florence Pecceu,(unknown),Jean‐Pierre Maffrand,Gérard Le Fur,Pierre Casellas	396
11	Effects of Divalent Cations and of a Calcimimetic on Adrenocorticotropic Hormone Release in Pituitary Tumor Cells 1997 ·Biochemical and Biophysical Research Communications ·Sandrine Ferry,(unknown),Robert H. Dodd,(unknown),Danielle Gully,Jean‐Pierre Maffrand,Martial Ruat	36
12	Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators 1996 ·Journal of Cellular Physiology ·Zhongchao Han,Sylvia Bellucci,Zhixiang Shen,Jean‐Pierre Maffrand,Marc Pascal,Maurice Petitou,J C Lormeau,J Caen	40
13	SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors 1994 ·Journal of Cellular Physiology ·C Klein-Soyer,Jean‐Pierre Cazenave,J. M. Herbert,Jean‐Pierre Maffrand	15
14	Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes 1993 ·Biochemical Pharmacology ·Jean‐Marc Herbert,(unknown),Jean‐Pierre Maffrand	8
15	Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel 1992 ·Biochemical Pharmacology ·Pierre Savi,Jean‐Marc Herbert,(unknown),F. Dol,Denis Delebassée,Jean Combalbert,G. Defreyn,Jean‐Pierre Maffrand	161
16	Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis. 1991 ·Journal of Clinical Investigation ·C. Serradeil‐Le Gal,(unknown),A Sanchez-Bueno,Danielle Raufaste,B. Roche,Anne-Marie Préaux,Jean‐Pierre Maffrand,P H Cobbold,Jacques Hanoune,Sophie Lotersztajn	98
17	The total synthesis of (+)-ryanodol. Part III. Preparation of (+)-anhydroryanodol from a key pentacyclic intermediate 1990 ·Canadian Journal of Chemistry ·Pierre Deslongchamps,André Bélanger,Daniel Berney,(unknown),(unknown),Alain Doutheau,Robert Durand,Hajime Katayama,(unknown),(unknown),Chun‐Chen Liao,(unknown),Jean‐Pierre Maffrand,(unknown),Robert Martino,Claude Moreau,Luc Ruest,(unknown),(unknown),Pierre Soucy	15
18	Characterization of specific binding sites for [3H]-staurosporine on various protein kinases 1990 ·Biochemical and Biophysical Research Communications ·Jean‐Marc Herbert,(unknown),Jean‐Pierre Maffrand	156
19	Tumor-promoting phorbol esters stimulate bovine cerebral cortex capillary endothelial cell growth in vitro 1989 ·Biochemical and Biophysical Research Communications ·(unknown),Jean‐Marc Herbert,Jean‐Pierre Maffrand	19
20	Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro 1988 ·Biochemical Pharmacology ·J. M. Herbert,(unknown),(unknown),Jean‐Marie Pereillo,Jean‐Pierre Maffrand	30

About Jean‐Pierre Maffrand

Jean‐Pierre Maffrand is a scholar working on Internal Medicine, Endocrine and Autonomic Systems and Cellular and Molecular Neuroscience, having authored 90 papers that have together received 5.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (15 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (10 papers). The work is most often cited by research in Behavioral Neuroscience (518 citations), Endocrine and Autonomic Systems (677 citations) and Internal Medicine (352 citations). Jean‐Pierre Maffrand has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include Jean‐Marc Herbert, Marc Pascal, Philippe Soubrié, Pierre Savi, Gérard Le Fur, Jean‐Marie Pereillo, C. Picard, Claudine Serradeil‐Le Gal, Jean Combalbert and B. Scatton. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact